99.5% up by HPLC US...

99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9
99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9
99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9
99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9
99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9

99.5% up by HPLC USP BP GMP DMF entecavir monohydrate 209216-23-9

Min.Order / FOB Price:Get Latest Price

25 Kilogram

Negotiable

  • Min.Order :25 Kilogram
  • Purity: 99.5% up
  • Payment Terms : L/C,D/A,D/P,T/T

Keywords

Entecavir Entecavir monohydrate Entecavir powder

Quick Details

  • Appearance:White powder
  • Application:anti-HIV, anti-HBV
  • PackAge:1kg/bag ;25kg/drum
  • ProductionCapacity:10|Metric Ton|Month
  • Storage:Dry place
  • Transportation:dry place

Superiority:

Why is SINOWAY:

1) Specialized in pharmaceutical and healthcare industrial for 34 years.

2) ISO 9001:2015 & SGS audited supplier . 

3) Accept various payment terms : T.T 30-60 days.

4) We have warehouse in USA with quickly shipment .

5) We can do different terms of FOB ,CIF/CIP ,DDP ...

 

Details:

 

Hepatitis B virus (hepatitis B virus, HBV) infection is prevalent worldwide, but the prevalence of HBV infection varies greatly in different regions. Currently, there are 5 popular oral nucleoside (acid) analog drugs: Entecavir (ETV), Tenofovir (tenofovir, TDF), Telbivudine (LdT), Adefovir dipivoxil (adefovir, ADV), lamivudine (lamivudine, LAM). Entecavir is currently one of the first-line drugs for the antiviral treatment of patients with chronic hepatitis B recommended by the World Health Organization and national guidelines.

Entecavir, as a potent oral guanosine nucleoside analog, can selectively inhibit HBV replication. It can be phosphorylated into active triphosphates in cells and interacts with HBV reverse transcriptase natural substrate deoxyguanine triphosphate. Nucleoside competition produces drug effect. Compared with other nucleoside (acid) drugs, Entecavir has the characteristics of low incidence of resistance mutation, strongest antiviral effect and moderate price. To date, the database of the CFDA Drug Evaluation Center shows that there are more than 10 approved formulations of Entecavir.

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View